Researchers are developing a new anti-epileptic drug that will become active during a seizure and benefit all epileptics, especially those who do not respond to currently available medication. The new drug will aim to inhibit a protein found in all people but which acts to prolong seizures in epilepsy sufferers. Around one per cent of the world’s population suffers from epilepsy and 30 per cent of sufferers do not respond to available drugs.
Read more at University of Newcastle
Academic rigor, journalistic flair
Want to write?
Write an article and join a growing community of more than 182,300 academics and researchers from 4,941 institutions.